Rasuvo

NDC 59137-505 · Medexus Pharma Inc.

Generic namemethotrexate

Dosage formINJECTION, SOLUTION

RouteSUBCUTANEOUS

Active ingredient(s)METHOTREXATE SODIUM

Strength7.5 mg/.15mL

Pharmacologic classFolate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]

Marketing categoryNDA

Packages

59137-505-01 — 1 PACKAGE in 1 CARTON (59137-505-01) / .15 mL in 1 PACKAGE (59137-505-00)

59137-505-04 — 4 PACKAGE in 1 CARTON (59137-505-04) / .15 mL in 1 PACKAGE (59137-505-00)

FDA lists these products with the same active ingredient.

51079-670 — methotrexate, 51285-366 — Methotrexate, 51285-367 — Methotrexate, 51285-368 — Methotrexate, 51285-369 — Methotrexate, 51407-121 — methotrexate, 55150-510 — METHOTREXATE, 55150-511 — METHOTREXATE, 55150-512 — METHOTREXATE, 55150-513 — METHOTREXATE, 59137-510 — methotrexate, 59137-515 — methotrexate, 59137-520 — methotrexate, 59137-525 — methotrexate, 59137-530 — methotrexate, 59137-535 — methotrexate, 59137-540 — methotrexate, 59137-550 — methotrexate, 59651-182 — Methotrexate, 61703-124 — Methotrexate, +34 more

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.